Literature DB >> 16884739

Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction.

Jan van Amsterdam1, Reinskje Talhout, Wim Vleeming, Antoon Opperhuizen.   

Abstract

Whole-body PET-scan studies in brains of tobacco smokers have shown a decrease in monoamine oxidase (MAO) activity, which reverts to control level when they quit smoking. The observed decrease in MAO activity in smokers is presumably due to their exposure to tobacco constituents that possess MAO-inhibiting properties. The inhibition of MAO activity seems, however, not to be a unique feature of tobacco smoking as subjects with Type II alcoholism have been reported to show a similar decrease in MAO activity that reverses when they cease to use alcohol. The present review summarizes the data on MAO-inhibiting tobacco constituents and explains that the decrease in MAO activity observed in alcoholics is probably due to concomitant tobacco use. It is concluded that the inhibition of MAO by constituents contained in tobacco and tobacco smoke, enhances the addiction induced by tobacco smoking.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16884739     DOI: 10.1016/j.lfs.2006.06.010

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Markov model of smoking cessation.

Authors:  Peter R Killeen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-20       Impact factor: 11.205

2.  Differential effects of non-nicotine tobacco constituent compounds on nicotine self-administration in rats.

Authors:  Brandon J Hall; Corinne Wells; Cheyenne Allenby; Mung Yan Lin; Ian Hao; Lindsey Marshall; Jed E Rose; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2014-02-21       Impact factor: 3.533

3.  Cigarette smoke exposure greatly increases alcohol consumption in adolescent C57BL/6 mice.

Authors:  Benjamin E Burns; William R Proctor
Journal:  Alcohol Clin Exp Res       Date:  2012-07-24       Impact factor: 3.455

4.  In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.

Authors:  Michel Bottlaender; Héric Valette; Jacques Delforge; Wadad Saba; Ilonka Guenther; Olivier Curet; Pascal George; Frédéric Dollé; Marie-Claude Grégoire
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-18       Impact factor: 6.200

Review 5.  Nicotine vaccines to assist with smoking cessation: current status of research.

Authors:  Tobias Raupach; Philippe H J Hoogsteder; Constant P Onno van Schayck
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

6.  The influence of monoamine oxidase variants on the risk of betel quid-associated oral and pharyngeal cancer.

Authors:  Ping-Ho Chen; Bin Huang; Tien-Yu Shieh; Yan-Hsiung Wang; Yuk-Kwan Chen; Ju-Hui Wu; Jhen-Hao Huang; Chun-Chia Chen; Ka-Wo Lee
Journal:  ScientificWorldJournal       Date:  2014-10-15

7.  Relationship of Anxiety and Depression with Respiratory Symptoms: Comparison between Depressed and Non-Depressed Smokers in Singapore.

Authors:  Cyrus S H Ho; Elysia L Y Tan; Roger C M Ho; Marcus Y L Chiu
Journal:  Int J Environ Res Public Health       Date:  2019-01-08       Impact factor: 3.390

8.  Effects of prenatal synthetic cannabinoid exposure on the cerebellum of adolescent rat offspring.

Authors:  Priyanka D Pinky; Mohammed Majrashi; Ayaka Fujihashi; Jenna Bloemer; Manoj Govindarajulu; Sindhu Ramesh; Miranda N Reed; Timothy Moore; Vishnu Suppiramaniam; Muralikrishnan Dhanasekaran
Journal:  Heliyon       Date:  2021-04-13

Review 9.  Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers.

Authors:  Ping-Ho Chen; Qaisar Mahmood; Gian Luigi Mariottini; Tai-An Chiang; Ka-Wo Lee
Journal:  Biomed Res Int       Date:  2017-12-11       Impact factor: 3.411

10.  Antidepressant-induced reduction in betel-quid use in patients with depression: A pioneer clinical study.

Authors:  Chung-Chieh Hung; Chien-Hung Lee; Chia-Min Chung; Srinivasan Nithiyanantham; Hsien-Yuan Lane; Ying-Chin Ko
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.